[fcb5af]: / literature / by_gene / LTB.tsv

Download this file

# pmid doi year title Hugo_Symbol
1 31820339 10.1007/s40259-019-00398-7 2021 A Randomized, Double-Blind, Efficacy and Safety Study of PF-05280586 (a Rituximab Biosimilar) Compared with Rituximab Reference Product (MabThera<sup>®</sup>) in Subjects with Previously Untreated CD20-Positive, Low-Tumor-Burden Follicular Lymphoma (LTB-FL). LTB
2 33847924 10.1007/s12185-021-03151-5 2021 Pretreatment levels of serum soluble interleukin-2 receptor are useful in selecting the treatment regimen for newly diagnosed advanced-stage follicular lymphoma with low tumor burden. LTB
3 29504848 10.1080/08916934.2018.1446525 2019 Signalling pathways identified in salivary glands from primary Sjögren's syndrome patients reveal enhanced adipose tissue development. LTB
4 29665320 10.1002/cjp2.97 2019 Reduced lymphotoxin-beta production by tumour cells is associated with loss of follicular dendritic cell phenotype and diffuse growth in follicular lymphoma. LTB
5 29377265 10.1111/jgh.14100 2018 Watch-and-wait policy versus rituximab-combined chemotherapy in Japanese patients with intestinal follicular lymphoma. LTB
6 26382560 10.3109/00365521.2015.1087589 2016 The role of watch and wait in intestinal follicular lymphoma in rituximab era. LTB
7 26456771 10.1111/bjh.13760 2016 Lymphotoxin-β receptor in microenvironmental cells promotes the development of T-cell acute lymphoblastic leukaemia with cortical/mature immunophenotype. LTB
8 25211095 10.18632/oncotarget.2390 2015 Methylation of miR-155-3p in mantle cell lymphoma and other non-Hodgkin's lymphomas. LTB
9 23233615 10.1182/asheducation-2012.1.433 2013 Is there a role for watch and wait in follicular lymphoma in the rituximab era? LTB
10 20001230 10.3109/10428190903350397 2010 Genetic changes including gene copy number alterations and their relation to prognosis in childhood acute myeloid leukemia. LTB
11 18561999 10.1016/j.leukres.2008.05.005 2008 5-LOX, 12-LOX and 15-LOX in immature forms of human leukemic blasts. LTB
12 15914563 10.1182/blood-2004-10-3898 2005 Splenic marginal zone lymphoma: proposal of new diagnostic and prognostic markers identified after tissue and cDNA microarray analysis. LTB
13 12801841 2004 Lymphotoxin beta expression is high in chronic lymphocytic leukemia but low in small lymphocytic lymphoma: a quantitative real-time reverse transcriptase polymerase chain reaction analysis. LTB
14 15035852 10.1089/107999004322917034 2004 Transcriptional response of T cells to IFN-alpha: changes induced in IFN-alpha-sensitive and resistant cutaneous T cell lymphoma. LTB
15 15240709 10.4049/jimmunol.173.2.1184 2004 Role of IFN regulatory factor-1 and IL-12 in immunological resistance to pathogenesis of N-methyl-N-nitrosourea-induced T lymphoma. LTB
16 10953976 10.3109/10428190009059274 2001 Tumour necrosis factor gene polymorphisms in lymphoproliferative disease. LTB
17 11092613 10.1007/s002620000127 2001 Expression of genes coding for the tumor necrosis factor and lymphotoxin ligand-receptor system in non-Hodgkin's lymphomas. LTB
18 9299492 10.1006/bbrc.1997.7277 1997 Identification of two lymphotoxin beta isoforms expressed in human lymphoid cell lines and non-Hodgkin's lymphomas. LTB
19 9317127 1997 Characterization of lymphotoxin-alpha beta complexes on the surface of mouse lymphocytes. LTB